GraniteShares Advisors LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1839545
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$698,364
-$467,461 QoQ
Shares Held
1,120
+1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#725
of 1,322 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GraniteShares Advisors LLC holds $2,939,290 across 5 Biotechnology names. REGN ranks #2 (23.8% of the industry book) .
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $698,364 | 1,120 | Shares | Sole | 2026-08-04 | |
| 2024-09-30 | $1,165,825 | 1,109 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,292,766 | 1,230 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,085,688 | 1,128 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $998,615 | 1,137 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,080,546 | 1,313 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $222,028 | 309 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $271,151 | 330 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $243,863 | 338 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $272,103 | 395 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $265,417 | 449 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $322,670 | 462 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $322,706 | 511 | Shares | Sole | 2022-02-08 | |
| No filing history on record for this holder in this stock. | ||||||